Home » Topics » Disease categories and therapies » Immune

Immune
RSS

IDEC-131, an inhibitor of B-cell activation for the treatment of autoimmune disorders

April 23, 1999

GPC and MorphoSys collaborate on human therapeutic antibody program

April 23, 1999

Inhibitors of PTKs and T-cell activation/proliferation in development at BMS

April 22, 1999

Belgian research team designs potent, irreversible and stable DPP IV inhibitors

April 21, 1999

Rodent and early human studies support feasibility of transcutaneous immunization

April 21, 1999

First CpG DNA-based immunotherapeutic enters human trials

April 20, 1999

Potential C. albicans vaccine tested in mice

April 20, 1999

Immune Response describes herpes vaccine research at FASEB 99

April 19, 1999

Compounds and methods for treating or diagnosing leishmaniasis disclosed by Corixa

April 16, 1999

Epimmune publishes studies on hepatitis, malaria vaccine development

April 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...